Atlas Trials

Myopericarditis After Messenger Ribonucleic Acid (mRNA) COVID-19 Vaccination in Children 5-11 Years Old

Clinical trial NCT05186571 · UNKNOWN

Trial details

NCT number
NCT05186571
Sponsor
Rigshospitalet, Denmark
Status
UNKNOWN
Study type
OBSERVATIONAL
MyopericarditisMyocarditisVaccination; ComplicationsCOVID-19 PandemicSARS-CoV2 Infection
Start date
2021-12-01
Primary completion
2022-03-01
Enrollment
350000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.